ArticleNature2022
How common is long COVID? Why studies give different answers.
Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed.
- Cardiovascular sequelae of Long COVID: immune dysregulation inflammation as central drivers.Frontiers in immunology · 2026Review
- Long COVID Disproportionately Reported by Disadvantaged Individuals: A National Survey of U.S. Working-Age Adults.Journal of general internal medicine · 2025Article
- Severe Acute SARS-CoV-2 Infection and Long COVID: What Do We Know So Far? New Challenges in Diagnosis and Management.Diseases (Basel, Switzerland) · 2025Article
- Long COVID Incidence Proportion in Adults and Children Between 2020 and 2024: An Electronic Health Record-Based Study From the RECOVER Initiative.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025Article
- Opportunities and Challenges in Using Electronic Health Record Systems to Study Postacute Sequelae of SARS-CoV-2 Infection: Insights From the NIH RECOVER Initiative.Journal of medical Internet research · 2025Article
- Lessons Learned From Characterizing Long COVID Among US Medicare Beneficiaries.Pharmacoepidemiology and drug safety · 2025Article
- Clinical and functional assessment of SARS-CoV-2 sequelae among young marines - a panel study.Lancet regional health. Americas · 2024Article
- Wearable Devices for Long COVID: Prospects, Challenges and Options.Asian bioethics review · 2024Article
- Prevalence, risk factors and characterisation of individuals with long COVID using Electronic Health Records in over 1.5 million COVID cases in England.The Journal of infection · 2024Article
- Long COVID science, research and policy.Nature medicine · 2024Review
- Interplay between Comorbidities and Long COVID: Challenges and Multidisciplinary Approaches.Biomolecules · 2024Review
- Piecing together the narrative of #longcovid: an unsupervised deep learning of 1,354,889 X (formerly Twitter) posts from 2020 to 2023.Frontiers in public health · 2024Article
- One-year post-acute COVID-19 syndrome and mortality in South Korea: a nationwide matched cohort study using claims data.Frontiers in public health · 2024Article
- The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches.Frontiers in immunology · 2024Review
- Unsupervised machine learning to investigate trajectory patterns of COVID-19 symptoms and physical activity measured via the MyHeart Counts App and smart devices.NPJ digital medicine · 2023Article
- Predictors of the post-COVID condition following mild SARS-CoV-2 infection.Nature communications · 2023Article
- Post-COVID health-related quality of life and somatic symptoms: A national survey in Japan.The American journal of the medical sciences · 2023Article
- Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron.Journal of patient-reported outcomes · 2023Article
- Long COVID in autoimmune rheumatic diseases.Rheumatology international · 2023Review
- De-black-boxing health AI: demonstrating reproducible machine learning computable phenotypes using the N3C-RECOVER Long COVID model in the All of Us data repository.Journal of the American Medical Informatics Association : JAMIA · 2023Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
35725828What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.